tüüp : |
ajaleht |
interneti link : |
https://doi.org/10.1007/s40259-019-00342-9 |
|
uurimisrühmad : |
Grenade - Faculty of Science, Department of Analytical Chemistry |
Autor : |
Hermosilla J, Sanchez-Martin R, Pérez-Robles R, Salmeron-Garcia A, Casares S, Cabeza J, Cuadros-Rodriguez L, Navas N. |
pealkiri : |
Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA). |
publikatsioon : |
Bio Drugs ; 33: 193–205. 2019 |
|
Tõendite tase : |
|
füüsikaline stabiilsus : |
|
Keemiline püsivus : |
|
Muud meetodid : |
|
Kommentaarid : |
Valgud: bioloogiline aktiivsus rakukultuuris |
|
ingredientide nimekiri
Infliximab
|
|
|
|
|
10 mg/ml |
2-8°C |
|
14 |
|
|
|
|
|
|
10 mg/ml |
2-8°C |
|
14 |
|
|
|
|
|
|
0,4 mg/ml |
2-8°C |
|
14 |
|
|
|
|
|
|
0,4 mg/ml |
2-8°C |
|
14 |
|
|
|
|
|
|
2 mg/ml |
2-8°C |
|
14 |
|
|
|
|
|
|
2 mg/ml |
2-8°C |
|
14 |
|
|
|
|
|